FZD3

There are 2 papers on FZD3 in aging research: none in people yet, 1 in animals, 1 in cells.

Gene

2 papers study it2 findings

HGNCNCBI GeneTaxon

See all 2 papers on FZD3

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Institute for Intelligent Healthcare, Tsinghua University
  • Animals1
  • Cells1

Upstream

2

EP300

upin human cells1

1 study
  1. EP300 increases FZD3 in human cells (recruited by NEAT1; acts via histone acetylation).

    “P300, an important histone acetyltransferases (HAT), recruited by NEAT1 to bind to FZD3 promoter and mediated its transcription via regulating histone acetylation.”

    Cellsrecruited by NEAT1; acts via histone acetylation

    NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice

    Aging

More on EP300

NEAT1

upin human cells1

1 study
  1. NEAT1 increases FZD3 in human cells (shown by knockdown; acts via H3K27 acetylation at the FZD3 promoter).

    “Downregulation of NEAT1 inhibited Frizzled Class Receptor 3 (FZD3) transcription activity by suppressing H3K27 acetylation (H3K27Ac) at the FZD3 promoter.”

    Cellsshown by knockdown; acts via H3K27 acetylation at the FZD3 promoter

    NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice

    Aging

More on NEAT1

Latest